uridine triphosphate has been researched along with losartan potassium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garrido, F; Ludwig, U; Perretta, M; Valenzuela, D; Valladares, L | 1 |
| Andresen, J; Bryan, RM; Marrelli, SP; Shafi, NI | 1 |
1 review(s) available for uridine triphosphate and losartan potassium
| Article | Year |
|---|---|
Hormonal control of gene expression: differential activation of rat bone marrow RNA polymerases by erythropoietin and testosterone.
Topics: Amanitins; Animals; Bone Marrow; Cell Differentiation; DNA-Directed RNA Polymerases; Drug Synergism; Erythropoietin; Gene Expression Regulation; Guanosine Triphosphate; Models, Biological; Rats; RNA; RNA Polymerase I; RNA Polymerase II; RNA, Messenger; RNA, Ribosomal; Testosterone; Transcription, Genetic; Uridine Triphosphate | 1979 |
1 other study(ies) available for uridine triphosphate and losartan potassium
| Article | Year |
|---|---|
Erythropoietin potentiates EDHF-mediated dilations in rat middle cerebral arteries.
Topics: Animals; Biological Factors; Brain Injuries; Cerebrovascular Circulation; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Endothelial Cells; Erythropoietin; Male; Middle Cerebral Artery; Rats; Rats, Long-Evans; Receptors, Erythropoietin; Treatment Outcome; Uridine Triphosphate; Vasodilation; Vasodilator Agents | 2008 |